Paloma Partners Management CO Ionis Pharmaceuticals Inc Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $206,325 - $262,876	4,909 New	4,909 $212,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $3.33 Million - $4.43 Million	-73,486 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $3.14 Million - $4.17 Million	66,211 Added 910.12%	73,486 $3.49 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $340,833 - $444,138	7,275 New	7,275 $429,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $3.02 Million - $4.63 Million	-57,040 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $2.47 Million - $3.4 Million	57,040 New	57,040 $3.08 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $826,579 - $1.06 Million	-16,433 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $748,687 - $978,913	16,433	16,433 $834,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.